Here's why Cardno Limited shares were slammed 26% today

Down 43% since September, could Cardno Limited (ASX:CDD) be a buy?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Professional engineering and consulting firm Cardno Limited (ASX: CDD) shares have been slammed today after the company delivered a bleak profit forecast. The shares plunged as much as 25.8% to $3.57 early in the session before recovering marginally to trade at $3.74.

Following today's nosedive, the stock has dropped a massive 43% since the beginning of September, which compares to a 6% decline from the benchmark S&P/ASX 200 Index (Index: ^AXJO) (ASX: XJO).

Citing difficult conditions in Australia as a result of a reduction in capital investment in mining, oil and gas, Cardno announced that it expects its half-year profit to come in well below last year's $43.1 million result. In fact, it said it expected to report operating net profit after tax (NPAT) of between $27 million and $31 million for the half-year ending 31 December 2014.

The company said: "Cardno's construction materials testing and electrical engineering businesses in this sector are forecast to deliver $12 million less in EBIT (in this half)… reflecting both reduced revenue and lower margins."

Also impacting the company's performance has been the slower-than-anticipated start on new project wins and higher costs associated with business integration in the Americas. On a more positive note however, the company has recognised a pick-up in demand for infrastructure and urban development related engineering services in Australia, with a backlog now sitting at a record $939 million. This should result in an improved performance in the second half.

While Cardno has maintained a dividend of 36 cents per share over the last three years, today's profit warning may impact its ability to continue that trend.

Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »